| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 1,5500% | ₹122.2 0% | 800 | ₹1.85 68.18% | 24,02547.61% |
| - | - | 820 | - | - |
| - | - | 840 | ₹3.1 1.63% | 17,050-8.33% |
| 7750% | ₹131 0% | 850 | ₹3.9 -7.14% | 55,025-2.73% |
| - | - | 860 | ₹5.25 -13.93% | 20,150-10.34% |
| - | - | 870 | ₹6.25 -8.08% | 20,15036.84% |
| 1,5500% | ₹58.9 15.03% | 880 | ₹8 -5.32% | 65,8751.19% |
| 7750% | ₹44.4 0% | 890 | ₹9.55 -8.61% | 25,57510% |
| 1,10,050-4.05% | ₹52.55 3.24% | 900 | ₹12.25 -7.19% | 2,36,3752.69% |
| 28,67554.16% | ₹46.9 3.19% | 910 | ₹14.8 -10.3% | 33,32516.21% |
| 63,55041.37% | ₹39.3 1.55% | 920 | ₹18.2 -8.77% | 68,20017.33% |
| 82,92512.63% | ₹33.75 3.05% | 930 | ₹22.75 -6.37% | 42,6255.76% |
| 86,80028.73% | ₹28.05 1.81% | 940 | ₹27.35 -4.53% | 65,10029.23% |
| 1,50,350-1.02% | ₹23.25 1.52% | 950 | ₹32.6 -4.95% | 49,6006.66% |
| 2,44,125-1.86% | ₹18.85 0.53% | 960 | ₹39.2 -0.25% | 1,08,5001.44% |
| 1,54,225-2.45% | ₹15.55 0.97% | 970 | ₹46.2 1.42% | 64,3250% |
| 1,49,5752.11% | ₹12.25 -1.2% | 980 | ₹53.9 3.75% | 89,9000% |
| 79,825-4.62% | ₹10.1 4.66% | 990 | ₹41.2 -1.19% | 31,7750% |
| 4,93,67525.64% | ₹8.4 4.34% | 1,000 | ₹70.5 -2.15% | 1,21,6750% |
| 24,02514.81% | ₹6.15 17.14% | 1,010 | - | - |
| 61,225-3.65% | ₹4.8 1.05% | 1,020 | ₹60 0% | 6,9750% |
| 16,2755% | ₹3.6 -7.69% | 1,030 | - | - |
| 98,425-2.30% | ₹3.05 -1.61% | 1,040 | - | - |
| 27,900-2.70% | ₹2.65 10.41% | 1,050 | - | - |
| 44,175-10.93% | ₹2.1 61.53% | 1,060 | - | - |
| 44,1750% | ₹0.7 0% | 1,080 | - | - |
| 1,39,5001.69% | ₹0.85 41.66% | 1,100 | ₹135 0% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
